BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 24816947)

  • 1. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.
    Ramezani Tehrani F; Minooee S; Azizi F
    Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
    Anik Ilhan G; Yildizhan B; Pekin T
    Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
    Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
    Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study.
    Hosseinpanah F; Barzin M; Erfani H; Serahati S; Ramezani Tehrani F; Azizi F
    Clin Endocrinol (Oxf); 2014 Jul; 81(1):52-7. PubMed ID: 23844634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
    Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
    Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.
    Wang H; Cao H; Cao J; Zhang L
    Biomed Res Int; 2023; 2023():1508675. PubMed ID: 36814799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could "a body shape index" and "waist to height ratio" predict insulin resistance and metabolic syndrome in polycystic ovary syndrome?
    Behboudi-Gandevani S; Ramezani Tehrani F; Cheraghi L; Azizi F
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():110-4. PubMed ID: 27579518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiposity Indexes as Phenotype-Specific Markers of Preclinical Metabolic Alterations and Cardiovascular Risk in Polycystic Ovary Syndrome: A Cross-Sectional Study.
    Mario FM; Graff SK; Spritzer PM
    Exp Clin Endocrinol Diabetes; 2017 May; 125(5):307-315. PubMed ID: 28201826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
    Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
    Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome.
    Wiltgen D; Benedetto IG; Mastella LS; Spritzer PM
    Hum Reprod; 2009 Jul; 24(7):1726-31. PubMed ID: 19329517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Visceral Adiposity Index and Lipid Accumulation Products to Define Metabolically-Unhealthy Polycystic Ovary Syndrome in Asian Indian Women - A Cross Sectional Study.
    Shreenidhi RA; Mahey R; Rajput M; Cheluvaraju R; Upadhyay AD; Sharma JB; Kachhawa G; Bhatla N
    J Hum Reprod Sci; 2024; 17(1):50-57. PubMed ID: 38665608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid Accumulation Product Better Predicts Metabolic Status in Lean Polycystic Ovary Syndrome than that by Visceral Adiposity Index.
    Banu H; Morshed MS; Sultana T; Shah S; Afrine S; Hasanat MA
    J Hum Reprod Sci; 2022; 15(1):27-33. PubMed ID: 35494190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
    Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
    Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the visceral adiposity index in the assessment of metabolic syndrome of polycystic ovary syndrome patients: a new anthropometric index.
    Rocha ALL; Baêta T; Nazareth IR; Costa JM; Caporalli JD; Oliveira MA; Couto MG; Azevedo RC; Comim FV; Oliveira FR; Reis FM; Cândido AL
    Arch Gynecol Obstet; 2024 Apr; 309(4):1643-1649. PubMed ID: 38321350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
    Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
    Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.
    Vassilatou E; Lafoyianni S; Vassiliadi DA; Ioannidis D; Paschou SA; Mizamtsidi M; Panagou M; Vryonidou A
    Maturitas; 2018 Oct; 116():1-7. PubMed ID: 30244768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women.
    Wehr E; Gruber HJ; Giuliani A; Möller R; Pieber TR; Obermayer-Pietsch B
    J Clin Endocrinol Metab; 2011 Jun; 96(6):E986-90. PubMed ID: 21470992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral Adiposity Index and Lipid Accumulation Product as diagnostic markers of Metabolic Syndrome in South Indians with Polycystic Ovary Syndrome.
    Naghshband Z; Kumar L; Mandappa S; Niranjana Murthy AS; Malini SS
    J Hum Reprod Sci; 2021; 14(3):234-243. PubMed ID: 34759612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index.
    Borruel S; Moltó JF; Alpañés M; Fernández-Durán E; Álvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF
    PLoS One; 2014; 9(12):e114112. PubMed ID: 25479351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.